ID Genomics, Inc. announces the award of a National Institute of Health (NIH) Small Business Technology Transfer Phase II Research grant to develop its clonotyping technology for identifying and tracking drug-resistant bacteria.
Read More
Researchers at ID Genomics, Inc. have discovered that that thousands of disease-causing E. coli strains simplify into several dozens of families with distinct responses to antibiotics. IDG has developed a unique “barcode” to identify each of these families, using only a handful of genetic targets.
Read More
